Cannabidiol mediates epidermal terminal differentiation and redox homeostasis through aryl hydrocarbon receptor (AhR)-dependent signaling

被引:6
|
作者
Jang, Young Su [1 ]
Jeong, Sugyeong [2 ]
Kim, A. -ram [3 ]
Mok, Bo Ram [1 ]
Son, Su Ji [3 ]
Ryu, Jae-sang [3 ]
Son, Woo Sung [4 ]
Yun, Seok Kyun
Kang, Seunghyun
Kim, Hyun Jung [5 ]
Kim, Dong Hyun [3 ]
Shin, Jung U. [3 ,6 ]
机构
[1] CHA Univ, Sch Med, Dept Biochem, Seongnam, South Korea
[2] COSMAX BTI R&I Ctr, Seongnam, South Korea
[3] CHA Univ, Sch Med, Bundang CHA Med Ctr, Dept Dermatol, Seongnam, South Korea
[4] Novorex Inc, Seoul, South Korea
[5] Chungnam Natl Univ, Coll Med, Sejong Hosp, Dept Dermatol, Sejong, South Korea
[6] CHA Univ, Bundang CHA Med Ctr, Dept Dermatol, Coll Med, Yatap Ro 59, Seongnam 13496, South Korea
基金
新加坡国家研究基金会;
关键词
CBD; NHEKs; Epidermal equivalents; AhR; Antioxidant; Skin barrier; THC/CBD OROMUCOSAL SPRAY; CB1; SKIN; KERATINOCYTES; CANNABINOIDS; INFLAMMATION; MULTICENTER; EXPRESSION; MECHANISM; SYSTEM;
D O I
10.1016/j.jdermsci.2023.01.008
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Cannabidiol, a non-psychoactive phytocannabinoid, has antioxidant and anti-inflammatory activity in keratinocytes. However, the signaling pathway through which cannabidiol exerts its effect on keratinocytes or whether it can modulate keratinocyte differentiation has not been fully elucidated yet.Objective: We investigated whether cannabidiol modulates epidermal differentiation and scavenges reactive oxygen species through the aryl hydrocarbon receptor (AhR) in keratinocytes and epidermal equivalents.Methods: We investigated the cannabidiol-induced activation of AhR using AhR luciferase reporter assay, qRT-PCR, western blot, and immunofluorescence assays. We also analyzed whether keratinocyte differentiation and antioxidant activity are regulated by cannabidiol-induced AhR activation. Results: In both keratinocytes and epidermal equivalents, cannabidiol increased both the mRNA and protein expression of filaggrin, involucrin, NRF2, and NQO1 and the mRNA expression of the AhR target genes, including CYP1A1 and aryl hydrocarbon receptor repressor. Additionally, cannabidiol showed antioxidant activity that was attenuated by AhR knockdown or co-administration with an AhR antagonist. Moreover, cannabidiol increased the ratio of OVOL1/OVOL2 mRNA expression, which is a downstream regulator of AhR that mediates epidermal differentiation. In addition to increased expression of barrier-related proteins, cannabidiol-treated epidermal equivalent showed a more prominent granular layer than the control epidermis. The increased granular layer by cannabidiol was suppressed by the AhR antagonist. Conclusion: Cannabidiol can be a modulator of the AhR-OVOL1-filaggrin axis and AhR-NRF2-NQO1 signaling, thus indicating a potential use of cannabidiol in skin barrier enhancement and reducing oxidative stress.(c) 2023 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 70
页数:10
相关论文
共 50 条
  • [21] Role of Aryl hydrocarbon receptor and the effect of selective AhR modulators on T cell differentiation
    Mohinta, Sonia
    August, Avery
    Perdew, Gary
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [22] Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism
    M Diry
    C Tomkiewicz
    C Koehle
    X Coumoul
    K Walter Bock
    R Barouki
    C Transy
    Oncogene, 2006, 25 : 5570 - 5574
  • [23] Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism
    Diry, M.
    Tomkiewicz, C.
    Koehle, C.
    Coumoul, X.
    Bock, K. Walter
    Barouki, R.
    Transy, C.
    ONCOGENE, 2006, 25 (40) : 5570 - 5574
  • [24] Modulation of Aryl Hydrocarbon Receptor (AhR) Signaling in Mesenchymal Stem Cells by Tryptophan Metabolites
    Alhamad, Dima
    Bensreti, Husam
    Ellingwood, Ashley
    Dorn, Jennifer
    Bollag, Wendy
    Fulzele, Sadanand
    Isales, Carlos
    Hill, William
    Hamrick, Mark
    McGee-Lawrence, Meghan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 343 - 343
  • [25] The intersection between the aryl hydrocarbon receptor (AHR)- and retinoic acid-signaling pathways
    Murphy, Kyle A.
    Quadro, Loredana
    White, Lori A.
    VITAMIN A, 2007, 75 : 33 - 67
  • [26] Inhibition of aryl hydrocarbon receptor (AhR) signaling enhances nucleotide excision repair (NER)
    Haarmann-Stemmann, Thomas
    Frauenstein, Katrin
    Douki, Thierry
    Majora, Marc
    Tigges, Julia
    Grether-Beck, Susanne
    Esser, Charlotte
    Abel, Josef
    Fritsche, Ellen
    Krutmann, Jean
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S99 - S99
  • [27] Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia
    Mehta, Vatsal
    Vezina, Chad M.
    DIFFERENTIATION, 2011, 82 (4-5) : 211 - 219
  • [28] Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology
    Alhamad, Dima W.
    Bensreti, Husam
    Dorn, Jennifer
    Hill, William D.
    Hamrick, Mark W.
    McGee-Lawrence, Meghan E.
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2022, 69 (03) : R109 - R124
  • [29] Aryl hydrocarbon Receptor (AhR)- and AhR Repressor (AhRR)-dependent immunoregulation in defense against Salmonella Typhimurium infection
    Cengiz, S. C.
    Weighardt, H.
    Foerster, I.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 118 - 119
  • [30] Imazalil is an aryl hydrocarbon receptor (AhR) antagonist in AhR-dependent reporter human and rat hepatoma cells
    Van der Heiden, Edwige
    Bechoux, Nathalie
    Sergent, Therese
    Ribonnet, Laurence
    Schneider, Yves-Jacques
    Muller, Marc
    Pussemier, Luc
    Maghuin-Rogister, Guy
    Scippo, Marie-Louise
    TOXICOLOGY LETTERS, 2007, 172 : S203 - S204